- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06317038
To Evaluate the Performance of Total 30 (Lehifilcon A) Contact Lenses in Patients Using Digital Devices for Greater Than 8 Hours Per Day 5 Days Per Week Based on Subjective Reported Data.
April 29, 2025 updated by: Joseph Tauber, Tauber Eye Center
Performance of TOTAL30 (Lehfilcon A) Contact Lenses in Patients Using Digital Devices and 89814415
To evaluate the performance of Total 30® (lehfilcon A) contact lenses in patients using digital devices for greater than 8 hours per day 5 days per week based on subjective reported data.
Study Overview
Study Type
Interventional
Enrollment (Actual)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
Kansas City, Missouri, United States, 64111
- Tauber Eye Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Adult patients aged 18-40 of any sex and any race.
- Reports habitually using digital device usage (phone, Ipad, computer, social media, video streaming) for 8 hours or more per day 5 days per week with plans to continue the habit throughout the study.
- Wearing contact lenses for at least 13 hours daily 5 days per week.
- Spherical refractive error between -11.00 D and +6.00D with < -0.75 D of astigmatism.
- Willing to comply with the protocol instructions.
- Has read (or has had read to), understood, and signed an Informed Consent.
- Willing to not use any artificial tears, rewetting drops or dry eye treatments during the study.
Exclusion Criteria:
- Active ocular infection or ocular inflammatory disease.
- Presbyopic or pre-presbyopic that have a measured add power for reading.
- Current Total 30 contact lens wearer.
- Anterior basement membrane dystrophy or history of recurrent erosion syndrome or topographical abnormalities that might indicate ectasia or other corneal degenerative conditions.
- Current or previous diagnosis of dry eye disease; currently using a dry eye treatment including but not limited to artificial tears, rewetting drops or prescription treatments.
- History of severe / serious ocular pathology or other medical conditions that could result in an inability to safely complete the study.
- Participation by the patient in any other investigational study within the past 30 days.
- Unlikely to comply with protocol instructions for any reason (confusion, substance abuse, etc.). The Principal Investigator or the Medical Monitor reserves the right to declare a patient ineligible based on medical evidence that indicates the patient is unsuitable for the study.
- Inability to utilize Clear Care Cleaning solution.
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Digital Device uses for 8 hours per day
Observational responses from patients using digital devices for 8 hours per day will be given a monthly Total 30 Contact lens.
|
Patients will be give a contact lens for 1 month
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Likert question about comfort satisfaction while wearing Total 30 contact lenses on a typical day (> 13 hours of daily wear) after 1 month of wear and heavy digital device usage (>8 hours daily wear).
Time Frame: 1 month
|
Likert Questionaire: Strongly Disagree, Disagree, Neither Agree nor Disagree, Agree, Strongly Agree
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Likert responses to insertion comfort and overall vision, and heavy digital device use on a typical day after 1 month of wear.
Time Frame: 1 month
|
Likert Questionaire: Strongly Disagree, Disagree, Neither Agree nor Disagree, Agree, Strongly Agree
|
1 month
|
|
Results of subjective ratings of patients using Total 30 lenses and heavy digital device usage with VAS diary questionnaire.
Time Frame: 1 month
|
VAS diary: scale 0-100 (0=No Discomfort 100= Maximal Comfort)
|
1 month
|
|
Report on total daily wear time and digital device usage.
Time Frame: 1 month
|
Survey: Total number of hours
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 31, 2024
Primary Completion (Actual)
November 11, 2024
Study Completion (Actual)
December 1, 2024
Study Registration Dates
First Submitted
March 12, 2024
First Submitted That Met QC Criteria
March 12, 2024
First Posted (Actual)
March 19, 2024
Study Record Updates
Last Update Posted (Actual)
May 1, 2025
Last Update Submitted That Met QC Criteria
April 29, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 89814415
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data will not be shared.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eye Strain
-
Universiti Sains MalaysiaRecruitingDigital Eye Strain (DES)Malaysia
-
Laboratorios Sophia S.A de C.V.WithdrawnEye Strain | Eye Strain of Both Eyes
-
Sun Yat-sen UniversityCompleted
-
Universidade Nova de LisboaUniversity of Évora; NOVA Medical School | Faculdade de Ciências Médicas, Universidade... and other collaboratorsNot yet recruiting
-
University of ValladolidCompletedComputer Vision Syndrome | OSDI | Digital Eye StrainSpain
-
Lee, Steven, M.D.CompletedMyopia, | Hyperopia, | Astigmatism, | Presbyopia, | Eye Strain,
-
Superior UniversityActive, not recruiting
-
University of California, DavisCompleted
-
Alanya Alaaddin Keykubat UniversityRecruitingAdults | Reliability | Validity | Cultural Adaptation | Eye StrainTurkey
-
Franklin Health ResearchArtemis InternationalCompleted
Clinical Trials on Total 30 Contact Lens
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Southern College of OptometryRecruiting
-
CIBA VISIONCompleted
-
Bausch & Lomb IncorporatedCompleted
-
CooperVision, Inc.Completed
-
CIBA VISIONUniversity of WaterlooCompleted
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
University of RochesterCompleted